Study of oxycodone with nafamostat in healthy adults
Treatments studied
Part of Pain clinical trials.
This trial tests how a new combination of oxycodone and nafamostat works in the body. It is for healthy volunteers aged 18 to 55 to help understand the drug's safety and how it is processed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are generally healthy, with no serious medical conditions like heart, liver, kidney, or lung disease.
- You have not smoked or used nicotine products in the last year.
- You do not take most prescription or over-the-counter medications regularly, except for acetaminophen (Tylenol), hormone therapy, or hormonal birth control.
- You have no history of drug or alcohol abuse in the past 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a sustained-release tablet (oxycodone/naloxone) for cancer patients with severe pain and constipation caused by opioids. It aims to see how well the drug works in real-world conditions.
This early-stage study tests a new approach for opioid use disorder in adults. It aims to understand safety and how the treatment may work in people with opioid addiction.
This study compares two forms of an experimental drug called vonafexor to see how they work in the body and if they interact with other medications. It's for healthy volunteers to make sure the drug is safe before testing in patients with liver disease.
This trial tests a new implant form of the medicine nalmefene to see if it is safe and well-tolerated in healthy adults. It is an early-phase study that helps researchers understand how the body reacts to the implant before testing it in people with opioid use problems.
This study tests how a new form of the medicine obefazimod (a tiny tablet) is absorbed by the body, and whether people find it easy to take. It is for healthy adults ages 18–55 who are not taking other medications and are generally well.
This study tests how a new medication (VK4-116) affects the body, especially when taken with or without food. It's looking for healthy volunteers to help understand the medication's safety and how it is processed.
Hear when a new Pharmacokinetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.